Non-Fontan adult congenital heart disease transplantation survival is equivalent to acquired heart disease transplantation survival
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F16%3A00059959" target="_blank" >RIV/00023001:_____/16:00059959 - isvavai.cz</a>
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S0003497515017609" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0003497515017609</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.athoracsur.2015.10.088" target="_blank" >10.1016/j.athoracsur.2015.10.088</a>
Alternative languages
Result language
angličtina
Original language name
Non-Fontan adult congenital heart disease transplantation survival is equivalent to acquired heart disease transplantation survival
Original language description
Background. As a result of improved diagnostic methods, medical treatment, surgical correction, and palliation in childhood, there is a growing number of adult patients with congenital heart disease (CHD) who may experience heart failure and subsequently require heart transplantation (HT). Because of complex anatomy, previous operations, and frequently increased pulmonary vascular resistance (PVR), these patients represent a group with a higher risk of early mortality after transplantation. Methods. From May 1999 to December 2014, our institution performed 25 HTs in adult patients with end-stage CHD. We present our data and outcomes of transplantation in this group. Results. The median age at transplantation was 38 years (range, 18.4-53.7 years). Survival was 88% at 30 days, 88% at 1 year, and 77% at 5 years. We identified long donor heart ischemic time (>4 hours) as an important risk factor for early mortality. There was no significant difference in the survival of patients undergoing transplantation for CHD and patients undergoing transplantation for other diagnoses. Conclusions. With careful donor and recipient selection, adults with end-stage CHD undergoing HT can achieve excellent early and midterm survival, comparable to the survival of patients who undergo transplantation for other diagnoses. (C) 2016 by The Society of Thoracic Surgeons
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Annals of thoracic surgery
ISSN
0003-4975
e-ISSN
—
Volume of the periodical
101
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
1768-1774
UT code for WoS article
000375868500037
EID of the result in the Scopus database
—